MTOR and esophageal cancer: Moreover, through in vitro cell experiments and in vivo subcutaneous tumor models in mice, we validated that the knockdown of the key deubiquitination-related gene MTOR significantly inhibits the malignant biological behavior of esophageal cancer cells, suggesting its potential as a therapeutic target for esophageal cancer patients.